On August 6, the World Economic Forum announced the 2015 “Technology Pioneer†corporate selection list, with 49 companies from 10 countries in the world selected. The leaders of these technology pioneers dare to break the status quo and use the abundant investment capital in the market to seek technological breakthroughs in high-challenge areas such as medical , financial, digital security and energy. They solve the urgent challenges facing the world and fulfill their social citizenship roles while striving to achieve their entrepreneurial dreams. The following is a partial introduction of this selected company: Consumer Physics (Israel) Bio Scanner – Bring it, pack the sweetest melon! Imagine you can choose the sweetest melon by scanning the watermelons on the market. This is achieved with our SCiO, the world's first handheld molecular sensor. As the flagship product of Consumer Physics, SCiO includes a miniature spectrometer that can scan entities and display physical component information on mobile phones. With SCiO, users can understand the nutritional composition of food, detect plant life and identify pharmaceutical ingredients. EDITAS Medicine (United States) Remove disease genes – completely eliminate genetic diseases! Genome editing technology can effectively remove disease genes, which is now the most exciting new field of research. The founders of Editas Medicine have published a number of breakthrough research advancements in CRISPR/Cas9 and TALENs technologies. The company is entering a new discipline in human therapeutics to eradicate more diseases directly at the genetic level. EIMindA (Israel) Helmets that detect brain activity – essential for brain disease prevention ! ElMindA Ltd has produced a sensor-filled helmet that detects brain activity patterns and generates clinically meaningful Brain Network Activation (BNA?) brain maps. Using innovative signal processing techniques and pattern recognition technology, the BNA® algorithm detects early signs of brain disease, such as Alzheimer's disease, and monitors the recovery of concussed patients. The BNA? platform also helps drug development by tracking brain activity after medication. EpiBone (United States) Growing your own bones – no longer plagued by complications! In the United States alone, more than 900,000 people undergo bone-related surgery each year, including the risk of complications from transplanting bones. EpiBone is a revolutionary bone rebuilding company that helps patients "grow their own bones." EpiBone's advanced technology scans patients for bone defects and then uses the patient's autologous stem cells to grow a predetermined transplanted bone, which means simpler surgical procedures, more successful surgical results, and a shorter recovery phase.
Losing weight is a behavioral pattern aimed at reducing excess body fat and weight. Moderate weight loss reduces the risk of obesity and improves the health of patients with obesity complications.
Our company specializes in providing raw materials for weight loss, Garcinia Cambogia Extract, White Kidney Bean Extract, Green Tea Extract, etc.
Our company also provides OEM and ODM services
Topiramate Powder,Orlistat Capsule,Metformin Hcl Powder,Weight Loss Raw Materials XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.xianrhinebiotech.com
There are two main types of commonly used drugs for the treatment of obesity: one is appetite suppressants that act on the central nervous system: these drugs are also known as anorexia drugs, which reduce serotonin and norepinephrine by affecting the activity of neurotransmitters. Reintake, thereby reducing food intake, suppressing appetite and increasing basal metabolic rate for weight loss, such as sibutamin. There is also a lipase inhibitor that acts on the periphery: by blocking the absorption of part of the fat in the diet to achieve weight loss, patients requiring drug treatment with a BMI greater than 30kg/m2 and no comorbidities, or greater than 28kg/m2 with other comorbidities .
There are also some raw materials, orlistat, liraglutide, cetilistat, etc.
